Veltex Corporation Shareholder Update

CHICAGO, May 25, 2023 /PRNewswire/ — Veltex Corporation (  OTCQB:VLXC) (“Veltex”), a Health and Wellness Acquisition Firm, and its wholly owned subsidiary Veltex Medical, Inc. d/b/a Veltex Recovery Group (“VRG”), is pleased to report progress at its Mount Hope, West Virginia Campus. VRG has engaged Ms. Patricia A. Kelly as its Chief Administrative Officer for the … Read more

Healthcare Predictive Analytics Market Size Will Surpass $30.71 Bn by 2028, The Market to Witness Huge Growth More than 22% in Next 5 Years- Arizton

CHICAGO, May 25, 2023 /PRNewswire/ — According to Arizton’s latest research report, the healthcare predictive analytics market will grow at a CAGR of 22.23% from 2022-2028. To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3815 Healthcare Predictive Analytics Market Report by Arizton Browse In-Depth TOC on Healthcare Predictive Analytics Market137 – Tables123 – Charts309 – Pages … Read more

Ondas focais para Impotência sexual

Opção inovadora para o tratamento da disfunção erétil SÃO PAULO, 25 de maio de 2023 /PRNewswire/ — O tratamento inovador de ondas focais de baixa intensidade tem sido utilizado como uma opção não invasiva para o tratamento da disfunção erétil. Essa terapia é considerada uma inovação na medicina pois é a única que estimula a … Read more

Featuring Drug Repurposing Using Nanotechnology to Produce a Nebulizer Solution

DUBLIN, May 25, 2023 /PRNewswire/ — The “Technology Innovations and Growth Opportunities in Inhaled Therapeutics” report has been added to  ResearchAndMarkets.com’s offering. Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for … Read more

Cure Alzheimer’s Fund Receives $8,400 From Quincy Firefighters

IAFF Local 792 Delivers Donations to Support Research of Alzheimer’s Disease WELLESLEY HILLS, Mass., May 25, 2023 /PRNewswire/ — The International Association of Firefighters (IAFF) Local 792 in Quincy, Massachusetts, has presented Cure Alzheimer’s Fund with a contribution of $8,400 to Alzheimer’s disease research. Lt. Ralph Blight and Firefighter Tom Bowes presented the donation which … Read more

111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023

SHANGHAI, May 25, 2023 /PRNewswire/ — 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2023, before the U.S. market opens … Read more

Curasight: Interim report Q1 2023

COPENHAGEN, Denmark, May 25, 2023 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) hereby publishes the interim report Q1 2023. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report. Curasight’s CEO Ulrich Krasilnikoff comments: “During the first quarter … Read more

Government of Japan Expresses its Pledge of US$200 Million to GHIT Fund/UNDP Replenishment

“GHIT 3.0,” its third five-year plan announced. TOKYO, May 25, 2023 /PRNewswire/ — At the G7 Hiroshima Summit 2023, Prime Minister Fumio Kishida announced the Government of Japan’s pledge to contribute US$200 million to the Global Health Innovative Technology Fund (GHIT Fund)/United Nations Development Programme (UNDP). This pledge supports the GHIT Fund’s third phase of operations, … Read more

United States Small-Cell-Lung Cancer Epidemiology Report 2022-2042

DUBLIN, May 24, 2023 /PRNewswire/ — The “Small-Cell-Lung Cancer in the United States, 2022-2042: Cancer Populations USA Report and Data Dashboard” report has been added to ResearchAndMarkets.com’s offering. The Cancer Populations USA report series provides detailed descriptive epidemiology estimates, forecast out to 20 years, and insights, to support clinical trial design and enrolment, market opportunity assessment and … Read more

Piramal Pharma Limited Announces Consolidated Results for Q4 and FY2023

MUMBAI, India, May 24, 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the fourth quarter (Q4) and full year FY23 ended 31st March 2023. Consolidated Financial Highlights (In INR Crores) Particulars Quarterly Full Year Q4 FY23 Q4 FY22 YoYGrowth Q3 FY23 QoQGrowth FY23 FY22 YoYGrowth Revenue from … Read more